Company / Current Liabilities per Share
Corcept Therapeutics Incorporated Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.58
FY2025
5-year range
$0.41 / $1.58
FY2021-FY2025
Trend
+16.1%
vs FY2024
Sector context
#81 of 210
Health Care
What the data says
At $1.58, Corcept Therapeutics Incorporated's current liabilities per share ranks #130 of 210 in the Health Care sector. Current Liabilities per Share has increased for 4 consecutive years, from $0.41 in FY2021 to $1.58 in FY2025.
Based on SEC 10-K filings.
1.58 in FY2025 with a 5-year CAGR of +30.7%.
Increased from $0.97 to $1.58 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +32.2%
- 5-Year CAGR
- +30.7%
- 10-Year CAGR
- -
Sector benchmark
-90.0% below sector average
Key checks
Key Insights
- Corcept Therapeutics Incorporated's current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 16.1% year-over-year.
- Ranks #81 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.58 | +16.1% |
| FY2024 | $1.36 | +40.5% |
| FY2023 | $0.97 | +41.6% |
| FY2022 | $0.68 | +68.0% |
| FY2021 | $0.41 | -1.8% |
| FY2020 | $0.41 | +22.8% |
| FY2019 | $0.34 | +8.9% |
| FY2018 | $0.31 | +18.2% |
| FY2017 | $0.26 | +5.1% |
| FY2016 | $0.25 | +21.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026